| Serum-mediated inhibition of enzyme replacement therapy in Fabry disease M Lenders, J Stypmann, T Duning, B Schmitz, SM Brand, E Brand Journal of the American Society of Nephrology 27 (1), 256-264, 2016 | 126 | 2016 |
| The Yo-Yo intermittent tests: a systematic review and structured compendium of test results B Schmitz, C Pfeifer, K Kreitz, M Borowski, A Faldum, SM Brand Frontiers in physiology 9, 870, 2018 | 105 | 2018 |
| Longer work/rest intervals during high-intensity interval training (HIIT) lead to elevated levels of miR-222 and miR-29c B Schmitz, F Rolfes, K Schelleckes, M Mewes, L Thorwesten, M Krüger, ... Frontiers in physiology 9, 395, 2018 | 95 | 2018 |
| Salt controls endothelial and vascular phenotype K Kusche-Vihrog, B Schmitz, E Brand Pflügers Archiv-European Journal of Physiology 467, 499-512, 2015 | 66 | 2015 |
| Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant M Lenders, F Weidemann, C Kurschat, S Canaan-Kühl, T Duning, ... Orphanet journal of rare diseases 11, 1-9, 2016 | 64 | 2016 |
| Dose-dependent effect of enzyme replacement therapy on neutralizing antidrug antibody titers and clinical outcome in patients with Fabry disease M Lenders, LP Neußer, M Rudnicki, P Nordbeck, S Canaan-Kühl, ... Journal of the American Society of Nephrology 29 (12), 2879-2889, 2018 | 62 | 2018 |
| Multifocal white matter lesions associated with the D313Y mutation of the α-galactosidase A gene M Lenders, T Duning, M Schelleckes, B Schmitz, S Stander, A Rolfs, ... PLoS One 8 (2), e55565, 2013 | 58 | 2013 |
| Thromboembolic events in Fabry disease and the impact of factor V Leiden M Lenders, N Karabul, T Duning, B Schmitz, M Schelleckes, R Mesters, ... Neurology 84 (10), 1009-1016, 2015 | 53 | 2015 |
| Sex differences in high-intensity interval training–are HIIT protocols interchangeable between females and males? B Schmitz, H Niehues, L Thorwesten, A Klose, M Krüger, SM Brand Frontiers in physiology 11, 38, 2020 | 49 | 2020 |
| Mutation-specific Fabry disease patient-derived cell model to evaluate the amenability to chaperone therapy M Lenders, F Stappers, C Niemietz, B Schmitz, M Boutin, PJ Ballmaier, ... Journal of Medical Genetics 56 (8), 548-556, 2019 | 46 | 2019 |
| Association of left ventricular mass with the AGTR1 A1166C polymorphism Y Jin, T Kuznetsova, L Thijs, B Schmitz, Y Liu, K Asayama, SM Brand, ... American journal of hypertension 25 (4), 472-478, 2012 | 45 | 2012 |
| Effects of high-intensity interval training on optic nerve head and macular perfusion using optical coherence tomography angiography in healthy adults B Schmitz, P Nelis, F Rolfes, M Alnawaiseh, A Klose, M Krüger, N Eter, ... Atherosclerosis 274, 8-15, 2018 | 41 | 2018 |
| Characterization of drug-neutralizing antibodies in patients with Fabry disease during infusion M Lenders, B Schmitz, SM Brand, D Foell, E Brand Journal of Allergy and Clinical Immunology 141 (6), 2289-2292. e7, 2018 | 41 | 2018 |
| Impact of immunosuppressive therapy on therapy‐neutralizing antibodies in transplanted patients with Fabry disease M Lenders, D Oder, A Nowak, S Canaan‐Kühl, L Arash‐Kaps, ... Journal of internal medicine 282 (3), 241-253, 2017 | 40 | 2017 |
| Dose-response of high-intensity training (HIT) on atheroprotective miRNA-126 levels B Schmitz, K Schelleckes, J Nedele, L Thorwesten, A Klose, M Lenders, ... Frontiers in physiology 8, 349, 2017 | 37 | 2017 |
| Effects of high-intensity interval training on microvascular glycocalyx and associated microRNAs B Schmitz, H Niehues, M Lenders, L Thorwesten, A Klose, M Krüger, ... American Journal of Physiology-Heart and Circulatory Physiology 316 (6 …, 2019 | 35 | 2019 |
| Increased monocyte adhesion by endothelial expression of VCAM-1 missense variation in vitro B Schmitz, P Vischer, E Brand, K Schmidt-Petersen, A Korb-Pap, K Guske, ... Atherosclerosis 230 (2), 185-190, 2013 | 35 | 2013 |
| Renal function predicts long-term outcome on enzyme replacement therapy in patients with Fabry disease M Lenders, B Schmitz, J Stypmann, T Duning, SM Brand, C Kurschat, ... Nephrology Dialysis Transplantation 32 (12), 2090-2097, 2017 | 28 | 2017 |
| Identification of genetic markers for treatment success in heart failure patients: insight from cardiac resynchronization therapy B Schmitz, R De Maria, D Gatsios, T Chrysanthakopoulou, M Landolina, ... Circulation: Cardiovascular Genetics 7 (6), 760-770, 2014 | 27 | 2014 |
| Soluble Adenylyl Cyclase in Vascular Endothelium: Gene Expression Control of Epithelial Sodium Channel-α, Na+/K+-ATPase-α/β, and Mineralocorticoid Receptor B Schmitz, J Nedele, K Guske, M Maase, M Lenders, M Schelleckes, ... Hypertension 63 (4), 753-761, 2014 | 27 | 2014 |
Martin PaulMaastricht University在 maastrichtuniversity.nl 的电子邮件经过验证
